Dunhill Financial’s West Pharmaceutical WST Stock Holding History

Dunhill Financial’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$646	Hold	1	–	–	﹤0.01%	1090
2026 Q1	$338	Sell	1 -1	-50%	-$249	﹤0.01%	1165
2025 Q4	$668	Hold	2	–	–	﹤0.01%	888
2025 Q3	$423	Hold	2	–	–	﹤0.01%	867
2025 Q2	$552	Sell	2 -17	-89%	-$3.63K	﹤0.01%	843
2025 Q1	$4.22K	Sell	19 -1	-5%	-$276	﹤0.01%	597
2024 Q4	$6.49K	Buy	20 +4	+25%	+$1.26K	﹤0.01%	487
2024 Q3	$4.84K	Buy	16 +9	+129%	+$2.76K	﹤0.01%	561
2024 Q2	$2.43K	Buy	7 +1	+17%	+$353	﹤0.01%	527
2024 Q1	$2.29K	Buy	6 +1	+20%	+$370	﹤0.01%	467
2023 Q4	$1.71K	Buy	+5	New	+$1.77K	﹤0.01%	484

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dunhill Financial's WST Position: Q2 2026 in Review

Dunhill Financial held its West Pharmaceutical (WST) position steady in Q2 2026 at 1 share worth $646. The position accounts for ﹤0.01% of the portfolio, ranked #1090.

Dunhill Financial first reported a position in WST in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.49K in Q4 2024. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Dunhill Financial held 1 share of West Pharmaceutical worth $646 as of Q2 2026.
Dunhill Financial left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1090 holding.
Dunhill Financial first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
Dunhill Financial's West Pharmaceutical position peaked at $6.49K in Q4 2024.
832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.